Showing 1 - 2 results of 2 for search 'Die Sang', query time: 0.02s Refine Results
  1. 1
    Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2−metastatic breast cancer patients: a multicenter study (YOUNGBC-28)

    Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2−metastatic breast cancer patients: a multicenter study (YOUNGBC-28)... by Yifan Chen, Yizhao Xie, Die Sang, Ning Xie, Xinhua Han, Yanxia Zhao, Juanjuan Li, Jian Yue, Peng Yuan, Biyun Wang

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study

    Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study by Die Sang, Yanfang Su, Yurong Zhang, Yanfeng Guan, Shanmin Fan, Jintao Zhang, Lijun Zheng, Yanling Wang, Ying Guo, Zixuan Lei, Man Li, Peng Yuan

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: